KLAS report examines global PACS market

By AuntMinnie.com staff writers
November 26, 2012

A new report from market research firm KLAS shares PACS customer feedback that focuses primarily on the technology and functionality of the most recent software versions. Highlights for the report were announced at the 2012 RSNA meeting in Chicago.

In the report, "Radiology PACS Technology: The World Looks Under the Covers," PACS technology leaders are identified as those that offer meaningful and timely upgrades with expanded usability.

The top-rated PACS innovators have a track record of improvement, and these include Infinitt and Intelerad, who were strongly endorsed by their customers. Other top-rated innovators include DR Systems, McKesson, Novarad, and Sectra, who have all released better radiologist tools with recent upgrades.

Midtier companies also offer solid technology and innovation, but bring their products to market at a slower rate than the industry's top performers, according to the report. These companies include Carestream Health, Fujifilm Medical Systems USA, Merge Healthcare, and Philips Healthcare.

However, some vendors are falling behind in terms of development and functionality, according to KLAS. Agfa HealthCare, Cerner, GE Healthcare, and Siemens Healthcare were ranked in the bottom tier of PACS innovators, though they do offer some stability and integration, the report noted.

For more information about the PACS market, the report can be purchase online at www.KLASresearch.com/KLASreports.

KLAS sees rising demand for mobile x-ray
Demand for mobile x-ray systems is rising thanks to recent technology innovations, according to a new report from market research firm KLAS.
KLAS report evaluates enterprise imaging strategies
Most healthcare providers in the U.S. are in the early stages of forming an enterprise imaging strategy, according to a new study by research firm KLAS....
KLAS ultrasound survey rates OEMs' performance
Ultrasound vendors who respond well to provider needs and market changes -- including expansions in range of clinical use and growing volumes -- receive...
KLAS issues report on U.S. proton therapy market
A report from market research firm KLAS suggests that concerns about market saturation and the estimated cost of $150 million to $200 million to build...
KLAS: Breast tomo worth hype, but has issues
While the ability of digital breast tomosynthesis (DBT) to image the breast has lived "up to the hype," a new KLAS study found that the high cost of upgrading...

Copyright © 2012 AuntMinnie.com

Last Updated np 11/26/2012 12:27:29 PM